Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy

C Tay, A Tanaka, S Sakaguchi - Cancer cell, 2023‏ - cell.com
Regulatory T cells (Tregs) are abundant in tumor tissues, raising a question of whether
immunosuppressive tumor-infiltrating Tregs (TI-Tregs) can be selectively depleted or …

Tumor microenvironment signaling and therapeutics in cancer progression

A Goenka, F Khan, B Verma, P Sinha… - Cancer …, 2023‏ - Wiley Online Library
Tumor development and metastasis are facilitated by the complex interactions between
cancer cells and their microenvironment, which comprises stromal cells and extracellular …

VEGF/VEGFR-targeted therapy and immunotherapy in non-small cell lung cancer: targeting the tumor microenvironment

Y Zhao, S Guo, J Deng, J Shen, F Du… - … journal of biological …, 2022‏ - pmc.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) is the leading cause of death by cancer worldwide.
Despite developments in therapeutic approaches for the past few decades, the 5-year …

Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine

S Kumagai, K Itahashi, H Nishikawa - Nature Reviews Clinical …, 2024‏ - nature.com
Accumulating evidence indicates that aberrant signalling stemming from genetic
abnormalities in cancer cells has a fundamental role in their evasion of antitumour immunity …

[HTML][HTML] Targeting the tumor microenvironment: Potential strategy for cancer therapeutics

Q Babar, A Saeed, TA Tabish, M Sarwar… - Biochimica et Biophysica …, 2023‏ - Elsevier
Cellular and stromal components including tumor cells, immune cells, mesenchymal cells,
cancer-linked fibroblasts, and extracellular matrix, constituent tumor microenvironment …

[HTML][HTML] Advances in dendritic cell vaccination therapy of cancer

S Najafi, K Mortezaee - Biomedicine & Pharmacotherapy, 2023‏ - Elsevier
Traditionally, vaccines have helped eradication of several infectious diseases and also
saved millions of lives in the human history. Those prophylactic vaccines have acted through …

[HTML][HTML] Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies

H Liu, H Zhao, Y Sun - Seminars in Cancer Biology, 2022‏ - Elsevier
The tumor microenvironment (TME) is a major contributor to cancer malignancy including
development of therapeutic resistance, a process mediated in part through intercellular …

Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy

R Abou Khouzam, B Janji, J Thiery, RF Zaarour… - Seminars in Cancer …, 2023‏ - Elsevier
In cancer patients, immune cells are often functionally compromised due to the
immunosuppressive features of the tumor microenvironment (TME) which contribute to the …

Impaired function of dendritic cells within the tumor microenvironment

Z **ao, R Wang, X Wang, H Yang, J Dong… - Frontiers in …, 2023‏ - frontiersin.org
Dendritic cells (DCs), a class of professional antigen-presenting cells, are considered key
factors in the initiation and maintenance of anti-tumor immunity due to their powerful ability …

Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation

A Queen, HN Bhutto, M Yousuf, MA Syed… - Seminars in Cancer …, 2022‏ - Elsevier
The primary physiological process of respiration produces carbon dioxide (CO 2) that reacts
with water molecules which subsequently liberates bicarbonate (HCO–3) and protons …